p

pSivida

147 employees

EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Optometry
WetAMD
Glaucoma
Eye Disease
Retinal Disease
Ophthalmology
Medical
Health Care

Date founded

1987

Funding rounds raised

Total raised

$60M

from 3 investors over 3 rounds

p

pSivida raised $16M on January 3, 2021

Investors: Ocumension

p

pSivida raised $60M on February 13, 2019

Investors: CRG LP

p

pSivida raised $7M on March 13, 2014

Investors: RA Capital Management, L.P.

FAQ